We are pround to include news from our technologies, startups, licensees as well as funding opportunies. To this page we have collected news from our inventions and startups.

1.6.2017 Research based SFTec won the competition aiming to create new working places
10.4.2017 TimeGate receives funding from the European Union Structural Funds

KNL Networks receives the shipping2030 innovation award


Sapotech taking part in an EU funded project

SURCAST-project aims to develop online-monitoring systems and numerical models for defects identification in the steel casting process.


IndoorAtlas parners with Spottio for enhanced in-store experience

IndoorAtlas, startup of University of Oulu, the global leader in indoor positioning partners with Spottio, a pioneer in digitization of retail stores. 

14.2.2017 SfTec made collaboraton agreements with Global EcoSolutions Oy and DustComb Oy
26.1.2017 Luxmet in top 25 in Nordic Cleantech Open

Paras Biopharmaceuticals received Quality Choice Award

Paras Biopharmaceuticals has received the ESQR’s Quality Choice Prize 2016 from the European Society for Quality Research (ESQR) for their hard work and achievements, in the presence of the international business community for its commitment to quality, excellence and continuous improvement.

27.10.2017 KNL Networks raises $10 million
  KNL Newtworks, a startup company of University of Oulu, developes a new wireless communications system which works also at most extreme and isolated locations in Earth.

Paras Biopharmaceuticals got a multi-million international investment

Paras Biopharmaceuticals Finland Oy, a startup company of University of Oulu, has developed technology for the production of an osteoporosis drug which will result into a very economical production of the medicine.

It has recently secured necessary investment from a UK based ASAP Growth Ltd who has extensive entrepreneurial experience in pharmaceuticals. This multi-million-euro investment is a key enabler in bringing further development of the product and the potential expansion of activities in Oulu.

The technologies of Paras Biopharmaceuticals are partly based on the research made at research group of Prof. Lloyd Ruddock at the Faculty of Biochemistry and Molecular Medicine.